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Background: Increasing evidence suggests that use of augmented visual feedback could be a useful approach to
stroke rehabilitation. In current clinical practice, visual feedback of movement performance is often limited to the
use of mirrors or video. However, neither approach is optimal since cognitive and self-image issues can distract or
distress patients and their movement can be obscured by clothing or limited viewpoints. Three-dimensional motion
capture has the potential to provide accurate kinematic data required for objective assessment and feedback in the
clinical environment. However, such data are currently presented in numerical or graphical format, which is often
impractical in a clinical setting. Our hypothesis is that presenting this kinematic data using bespoke visualisation
software, which is tailored for gait rehabilitation after stroke, will provide a means whereby feedback of movement
performance can be communicated in a more meaningful way to patients. This will result in increased patient
understanding of their rehabilitation and will enable progress to be tracked in a more accessible way.
Methods: The hypothesis will be assessed using an exploratory (phase II) randomised controlled trial. Stroke
survivors eligible for this trial will be in the subacute stage of stroke and have impaired walking ability (Functional
Ambulation Classification of 1 or more). Participants (n= 45) will be randomised into three groups to compare the
use of the visualisation software during overground physical therapy gait training against an intensity-matched and
attention-matched placebo group and a usual care control group. The primary outcome measure will be walking
speed. Secondary measures will be Functional Ambulation Category, Timed Up and Go, Rivermead Visual Gait
Assessment, Stroke Impact Scale-16 and spatiotemporal parameters associated with walking. Additional qualitative
measures will be used to assess the participant’s experience of the visual feedback provided in the study.
Discussion: Results from the trial will explore whether the early provision of visual feedback of biomechanical
movement performance during gait rehabilitation demonstrates improved mobility outcomes after stroke and
increased patient understanding of their rehabilitation.
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Stroke is the largest cause of complex disability in adults
in the UK [1] and the third most common cause of
death worldwide [2]. Two-thirds of stroke survivors en-
counter problems in walking after stroke, with 30% still
unable to walk without assistance 6 months later [3,4].
Regaining walking function is a priority for stroke survi-
vors since this widely influences their status of inde-
pendence and thus quality of life [5]. Overground gait
training is a physical therapy intervention in which a
physiotherapist will observe, cue and facilitate a patient’s
walking pattern. It is commonly supplemented by prac-
tising walking and exercises purposely aimed at improv-
ing gait performance [4]. Stroke survivors will often
employ abnormal movement patterns to compensate for
reduced range of motion, strength and control. For ex-
ample, a typical characteristic of hemiplegic gait is hitch-
ing of the hip when stepping forward to compensate for
reduced hip and knee flexion. Patients are often unaware
of their compensatory movements, and physiotherapists
will aim to discourage these at an early stage by encour-
aging awareness of the position and orientation of their
limb segments.
Feedback of performance plays a central role in skill
acquisition. After a stroke, intrinsic feedback mechan-
isms are often impaired and so extrinsic (or augmented)
feedback is of great importance for motor relearning.
While there is plentiful literature to provide guidance in
the use of extrinsic feedback to promote motor learning
in the healthy population, more research is required to
inform the use of extrinsic feedback in stroke rehabilita-
tion [6,7]. Physiotherapists currently provide feedback in
various forms, including verbal comments and demon-
stration. In clinical practice, physiotherapists may also
use mirrors or video-recordings to provide patients with
visual feedback of their movement performance. These
allow patients to become aware of how they move and
correct any compensatory strategies. However, these
methods are not optimal after a stroke due to cognitiveFigure 1 A screenshot of the visualisation software showing gait perfand self-image issues. Viewpoints are often limited using
these techniques and fail to capture aspects of move-
ment sequences that would benefit from observation in
different planes. The ability to process information after
a stroke can be impaired, and mirror or video-
recordings present visual feedback within a relatively
complicated visual field: patients can be distracted by
the clinic background or distressed by their altered ap-
pearance as a result of their stroke; and the ability to ob-
serve subtle movements can be obscured by clothing.
Moreover, mirrors provide visual feedback as a reflected
image, which can cause difficulties for stroke survivors
who find it hard to differentiate left from right.
A recent review by Laver and colleagues suggested
that the use of virtual reality could be a useful approach
to stroke rehabilitation [8]. However, definitive conclu-
sions could not be drawn due to the small number and
sizes of studies reviewed and the diversity of virtual real-
ity applications (from commercial games to bespoke re-
habilitation programmes). Virtual reality has the
potential to increase patient motivation and engagement
in their rehabilitation. Many of these applications are
based on motivational games that encourage patients to
move through repetitive movements. However, although
these games may give a representation of the movement
abilities of a patient, they tend not to show how patients
move in context; that is, how limb segments move in re-
lation to each other. This project aims to use a virtual
reality platform to show stroke patients how they move
during gait re-education, whilst removing distractions
associated with mirrors or video feedback.
This study proposes to investigate a novel intervention
strategy that uses dynamic visualisations of the patient’s
movements to facilitate gait re-education. Movement
data will be captured in real-time using a three-
dimensional (3D) optical motion analysis system. The
software package will extract limb segment position and
orientation data of the pelvis and lower limbs and
present this numerical data using bespoke visualisations.ormance.
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sentation of the patient moving, which is shown to them
on a monitor. The stick figure mimics the user either in
real time or after they have completed the action de-
pending on the task and the patient’s ability to process
information. In this way stroke patients, and their phy-
siotherapists, will be provided with immediate, clear and
depersonalised visual feedback of their biomechanical
movement performance. Patients and their therapists
will be able to review gait performance (see Figure 1),
participate in virtual gait-related target exercises (see
Figure 2) and track progress in a more tangible way. The
software will be capable of showing users how they
move from different viewpoints, and will allow users to
zoom in and out and have speed control over replays of
their actions, whilst retaining the accuracy and numer-
ical data from 3D motion capture.
This study is part of a wider project called envisage. The
envisage project is a multicentre project with a principal
aim of promoting functional independence through dy-
namic visualisation of biomechanical data across a range
of rehabilitation settings. The collaborators are the Univer-
sity of Strathclyde, The Glasgow School of Art, and Glas-
gow Caledonian University. The project is being funded
by the Medical Research Council’s Lifelong Health and
Wellbeing initiative (grant number G0900583, ID 91021).
Primary research question
Will the early provision of augmented visual feedback of
biomechanical movement performance in gait rehabilita-
tion improve mobility outcomes after stroke?
Secondary research questions
What impact will the visualisations have on patients’:
understanding of their rehabilitation; motivation to
achieve their rehabilitation goals; confidence in theirFigure 2 A screenshot of a virtual, gait-related target exercise




The visualisation intervention will be tested in an ex-
ploratory (phase II) randomised controlled trial (RCT)
[9]. See Figure 3 for a flowchart of patient pathways. Par-
ticipants will be randomised into three groups: a control
group, a placebo group, and an intervention group that
receives augmented visual feedback.
Participants in the control group will continue with
their usual care only. The term usual care refers to ther-
apy provided by National Health Service (NHS) Lanark-
shire, UK. This could be community care, day hospital
care or no continued care, dependent on assessment of
the patient’s ability by their clinical team.
In addition to usual care, participants in the placebo
group will receive overground physical therapy gait
training. Gait training will be provided as 1-hour ses-
sions, twice weekly for 6 weeks. This training will consist
of walking practice and a predetermined pool of
walking-related exercises that study physiotherapists can
choose from. The exercises are based on hip, knee and
ankle range of motion in sitting and standing. Partici-
pants in this group will not receive any augmented visual
feedback of their movement. The study physiotherapist
will provide participants with feedback by demonstration
and verbal feedback only, as per conventional gait train-
ing. During gait training, participants’ movements will
be recorded using 3D optical motion capture. This will
involve placing small reflective markers on the pelvis
and lower limb segments.
In addition to usual care, participants in the interven-
tion group will receive overground physical therapy gait
training with augmented visual feedback of their move-
ment performance. Gait training with visual feedback will
be provided as 1-hour sessions, twice weekly for 6 weeks.
During these gait training sessions, participants’ move-
ments will be recorded using 3D optical motion capture,
as in the placebo group, and will be used to power our
bespoke visualisation software. In addition to feedback
by demonstration and verbal feedback, participants in
this group will receive augmented visual feedback in
which they will be able to see a stick figure on a com-
puter screen mimic their movements in real time. Ses-
sions will consist of walking practice and the same
predetermined pool of walking-related exercises as in the
placebo group. However, each of the exercises will in-
volve moving towards virtual targets. The virtual targets
will be superimposed on the stick figure visualisation so
that the patient is able to see how they move as they per-
form exercises. The study physiotherapist will have the
option to provide virtual targets for movements of hip
Figure 3 Outline of patient pathway in the randomised controlled trial.
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ankle dorsiflexion/plantarflexion and inversion/eversion.
The study physiotherapist will have control over set-
ting the ranges of motion for targets and the number
of repetitions so that exercises can be tailored to an
individual patient’s requirements. When to replay gait
performances and view patient progress over time
using the visualisations will be left to the study phy-
siotherapist’s discretion.
The study physiotherapist will lead and be responsible
for all clinical decision-making during placebo and inter-
vention gait training sessions. The researcher will be
present for technical support only. These sessions will be
video-recorded for post-hoc analysis. Observational ana-
lysis of this data will allow comparison of patient–therapist
interaction between intervention and placebo groups.
The primary outcome measure for this trial is walking
speed, which will be measured using the 5-metre walk
test [10]. Secondary outcome measures include the
Functional Ambulation Category (FAC) [11], Timed Up
and Go [12], Rivermead Visual Gait Assessment [13],
spatial symmetry (ratio of step lengths) and temporal
symmetry (ratio of step times), and the Stroke Impact
Scale-16 [14]. Outcome assessments will be conducted
at baseline, 6-week outcome and 6-month follow-up.
The study physiotherapist will be present to assist parti-
cipants during functional assessments only. The study
researcher will be present to take measures and for tech-
nical support. To minimise patient burden during out-
come assessments, participants will be instructed to do
the 5-metre walk test four times and the Timed Up and
Go test three times, if capable, while walking over agridded mat and being video-recorded. From these
recordings, an assessor blinded to treatment allocation
will be able to assess all functional outcomes post hoc.
The study researcher will help the participant complete
the Stroke Impact Scale-16 questionnaire if required.
Participants will be asked to complete a pre-trial ques-
tionnaire to determine what rehabilitation goals they
may have and to obtain self-reported motivation and
confidence levels. An additional questionnaire will be
conducted by the study researcher at the 6-week out-
come session. This will be used to gain further under-
standing of the impact and patient acceptance of the
visualisation package. The questionnaire will explore
whether the participant’s pre-trial goals have been
achieved and the effects of the use of augmented visual
feedback on patient motivation, confidence and under-
standing of their rehabilitation. The qualitative aspect of
this research will be in the form of semi-structured
interviews to gain further understanding of the impact
of augmented visual feedback. These interviews will be
carried out after participants have completed their 6-
week outcome assessments. To reduce bias, an inde-
pendent researcher, who has not been involved in the
RCT, will be responsible for designing and conducting
interviews with participants.
Impairments in the domains of attention and memory
could be covariates in skill acquisition. Knowing the
levels of impairment in these domains will enable us to
check whether this has had an impact on the effective-
ness of the intervention. The Rivermead Behavioural
Memory Test [15], the Test of Everyday Attention [16]
and the Line Cancellation Test [17] will therefore also
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will assess the safety of and patient adherence to the
visualisation package. Safety will be assessed by the
number and nature of adverse events throughout partici-
pation in the trial. Adherence will be assessed by the
number of sessions attended and the withdrawal or
dropout rate from the study. All therapy and outcome
assessment sessions received in addition to usual care as
part of the trial will take place at Coathill Day Hospital
and Wishaw General Hospital, NHS Lanarkshire, UK.Identification of eligible patients
Participants will be recruited from acute sites and com-
munity rehabilitation teams in NHS Lanarkshire, UK.
For full inclusion/exclusion criteria refer to Table 1. Po-
tential participants will be identified by their NHS direct
care team and/or stroke research nurses, who will ensure
that the patient is able to give informed consent with
suitable communication support if required. Written
informed consent will be obtained from all participants
prior to participation in the study.
The research nurse or researcher will go over the
study’s participant information sheet with the patient.
Patients will have the opportunity to ask any questions
and will be given a minimum of 24 hours to review the
information sheet and consider their participation in the
trial. During this time they will be able to ask any further
questions and talk to other people about the study. The
research nurse or researcher will then approach the pa-
tient again, answer any further questions and, if appro-
priate, gain consent from the patient who is to sign aTable 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Clinical diagnosis of stroke • Severe visual or cognitive
problems precluding
participation in the study
• In the subacute stage of stroke
(≤3 months since stroke onset)
• Involved in another physical
rehabilitation research trial
• Of either gender • Pre-existing lower limb deficits
or any other medical
comorbidities that interfere
significantly with gait.
• Age ≥18 years
• Exhibit an abnormal gait pattern
Functional Ambulation Category
of 1 or more
• Medically stable and hence
suitable for physical rehabilitation
• Able to understand and follow
simple instructions
• Able to give informed consent
when assisted to do so with
suitable communication aids if
requiredconsent form. This study complies with data-protection
legislation. Upon enrolment in the study, patients will be
allocated a unique trial number that will be used in all
case-report file documents. Patient names will be used
to arrange appointments only and will not be used for
data-collection purposes. Where a patient is deemed eli-
gible and provides informed consent, the following
demographic and stroke information will be collected:
age, sex, postcode, date of stroke, side affected, domin-
ant side, pre-stroke function (FAC score) and type of
stroke (Oxford Stroke Classification) [18].
Data collection equipment
The 3D motion analysis will be carried out using an
eight-camera Optitrack optical motion capture system
(NaturalPoint, Corvallis, Oregon, USA). This will involve
attaching small reflective markers on anatomical land-
marks on the pelvis and lower limbs. The visualisation
software will extract movement data from the motion
capture system and present the data using bespoke
visualisations.
Sample size
A GPower a priori analysis for a mixed (2 × 3) analysis
of variance was carried out. Setting α at 0.05 and 1β at
0.8, with an effect size of 0.2, this predicted a total sam-
ple size of 42. On this basis, and accounting for roughly
a 10% drop out, we estimated that 45 participants (15
per group) would be sufficient to minimise the risk of
type 1 or type 2 errors. We anticipate that results from
this pilot study will yield data for a sample size estima-
tion for a future definitive RCT.
Randomisation method
The randomisation sequence will be generated using an
independently verified S-PLUS program (Robertson
Centre for Biostatistics, University of Glasgow, UK). This
program uses a stratified permuted block randomisation
procedure, with stratification based on the severity of
walking impairment. This stratification will ensure that
intervention groups are balanced, since severity of im-
pairment influences the potential for recovery. Severity
of walking impairments will be classified using the FAC.
Stratification will consist of two groups: FAC 1 to 3, and
FAC 4 to 5. The researcher will access intervention allo-
cations through the study web portal, designed and
maintained by The Robertson Centre for Biostatistics at
the University of Glasgow. The randomisation sequence
will be concealed until the participant’s details are logged
on the system.
Statistical analysis
Data will be analysed on an intention to treat basis. Data
will be held independently on a database at the Glasgow
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sets for each randomisation allocation will be compared
by independent blinded assessors.
Descriptive statistics will be calculated and the charac-
teristics of the population will be described. Two mixed-
design analysis of variance models will be used to test
for mean differences between the three arms of the RCT,
while subjecting participants to repeated measures. The
repeated measures will be examined for differences over
time and between groups. If appropriate, factors that
may affect the outcome of the trial – such as differences
in time since onset of stroke, age, severity of stroke or
memory and attention levels – will be investigated using
demographic and stroke-related information collected at
baseline.
Data collected from pre-trial and post-trial interviews
by the study researcher and in-depth semi-structured
interviews by an independent researcher will be suitably
coded such that qualitative responses can be categorised
and explored.Discussion
This protocol describes a phase II (or exploratory) RCT
that aims to explore the effect of using visual feedback
of biomechanical movement performance as an adjunct
to gait training after stroke. Stroke survivors and stroke
rehabilitation professionals, clinicians and academics,
have been involved in both the development of this
protocol and the visualisation software. Our findings
from informal semi-structured interviews and focus
groups have suggested that dynamic visualisations could
be a useful addition to gait rehabilitation after a stroke.
Involving users in the development of the software has
meant visualisations have been designed to specifically
complement lower-limb stroke rehabilitation.
Therapy and outcome sessions could possibly be influ-
enced by the knowledge and experience of individual
therapists. To reduce this variability, one physiotherapist
will lead all trial therapy sessions that are provided in
addition to the patient’s usual care.
The trial will focus on quantitative functional outcomes;
however, it will incorporate qualitative measures, includ-
ing patient-reported questionnaires, to aid in the explan-
ation of outcomes. Qualitative data capture will be
analysed to provide clarity on the impact of the visualisa-
tions with regards to participant confidence, motivation
and understanding of their rehabilitation programme as a
result of taking part in the trial. This single-site study, al-
though relatively small scale, is expected to provide valu-
able evidence to support the early mobilisation of stroke
survivors through visualisation of movement performance.
We anticipate that results will confirm benefits associated
with using visualisation of biomechanical data during gaittraining after stroke, and will be used to power a future
larger-scaled study.
Furthermore, the RCT aims to address whether the
visualisations will engage clients in their rehabilitation,
enabling them to perform to their optimal functional
capability. This method retains the accuracy and accessi-
bility of the biomechanical data required by clinicians
but presents the data in a nontechnical way, facilitating
enhanced communication between patient and physio-
therapist and patient understanding of their rehabilita-
tion. Patients will be able to see how they move and will
be able to observe any compensatory strategies they may
employ to complete rehabilitation tasks. This application
has the potential to enable patients to self-correct their
movement patterns and discourage overreliance on their
physiotherapists for corrective advice. Moreover, such a
stroke rehabilitation tool could provide the objective
training required for assessment during rehabilitation.
Tracking progress after a stroke can be difficult as
improvements can be small and can take place over long
periods of time. Retaining movement data over the re-
habilitation programme enables one to compare differ-
ent therapy sessions. For example, a physiotherapist
could visually view progress between baseline and conse-
quent sessions by pulling up saved files that display stick
figure visualisations mimicking how the user moved in
those particular sessions. This visualisation could in-
stantly allow the physiotherapist to get an idea of the
quality of the patient’s movements, and supporting nu-
merical data could also be accessed to compare ranges
of motion achieved over time.
Trial status
Ethical approval was obtained from NHS West of
Scotland Research Ethics Committee 2 on 26 April 2011
(Ref 11/AL/0184). NHS Lanarkshire R&D approval was
obtained on 5 April 2011. The trial commenced in
March 2012.
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